These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 12523885)
1. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Jonas JB; Kreissig I; Söfker A; Degenring RF Arch Ophthalmol; 2003 Jan; 121(1):57-61. PubMed ID: 12523885 [TBL] [Abstract][Full Text] [Related]
2. Intravitreal cortisone injection for refractory diffuse diabetic macular edema. Er H; Yilmaz H Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802 [TBL] [Abstract][Full Text] [Related]
3. Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema. Jonas JB; Spandau UH; Kamppeter BA; Vossmerbaeumer U; Harder B; Sauder G Ophthalmology; 2006 May; 113(5):800-4. PubMed ID: 16530840 [TBL] [Abstract][Full Text] [Related]
4. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306 [TBL] [Abstract][Full Text] [Related]
5. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema. Batioğlu F; Ozmert E; Parmak N; Celik S Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151 [TBL] [Abstract][Full Text] [Related]
14. Intravitreal triamcinolone acetonide for diabetic macular edema. Chieh JJ; Roth DB; Liu M; Belmont J; Nelson M; Regillo C; Martidis A Retina; 2005; 25(7):828-34. PubMed ID: 16205559 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Sutter FK; Simpson JM; Gillies MC Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes. Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema. Avitabile T; Longo A; Reibaldi A Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521 [TBL] [Abstract][Full Text] [Related]
18. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Bonini-Filho MA; Jorge R; Barbosa JC; Calucci D; Cardillo JA; Costa RA Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3845-9. PubMed ID: 16186372 [TBL] [Abstract][Full Text] [Related]
20. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA Retina; 2007; 27(9):1187-95. PubMed ID: 18046223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]